Karen Krok is a Professor of Medicine and a hepatologist at the Penn State Milton S. Hershey Medical Center. She serves as Vice Chair of Clinical Affairs for the Department of Medicine. She is also passionate about education and is an Associate Program Director for the Gastroenterology Fellowship.

Parissa Tabrizian, MD, MSc, FACS is a board-certified surgeon, associate professor of surgery who specializes in hepatobiliary and liver transplantation at the Recanati/Miller Transplantation Institute. Dr. Tabrizian earned her medical degree at the University of Vienna medical school and completed her general surgery residency at the Mount Sinai Medical Center in New York. She completed fellowships in surgical oncology and multiorgan transplant surgery at Mount Sinai Hospital. In 2015, Dr.

Dr. Ajmera is a current investigator in the UCSD Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Research Unit where he collaborates with a multidisciplinary team of experts on research in non-invasive biomarkers and patient factors associated with disease severity and prognosis. He is a recipient of an American Association for the Study of Liver Diseases (AASLD) Clinical and Translational Research Award and an NIDDK K23 Career Development Award for his work on the non-invasive assessment of patients with MASLD.

Dr. Lim is a Professor of Medicine and Vice-Chief of the Section of Digestive Diseases at Yale University School of Medicine where he serves as Director of Clinical Hepatology and Associate Medical Chief of YNHHS Digestive Health. He has served the AASLD in several roles, including the HBV SIG steering committee, Viral Hepatitis Elimination Taskforce, AASLD-IDSA HCV guidance panel, and AASLD-IDSA HBV guideline panel.

I received my MD at Russian University of Friendship, Moscow. I then studied biochemistry and immunology during my graduate studies at Christian-Albrecht University, Germany. As a postdoctoral fellow at Columbia University (USA), I studied signal transduction, and expanded my skills in transgenic mouse technologies. I joined UCSD as a principal investigator. The major interest of my research is the identification of new targets for the therapy of MASH and MetALD-associated liver fibrosis and cholestatic fibrosis.

Dr. Sonya MacParland, PhD, is the Research Institute Director and a senior scientist in the Ajmera Transplant Centre at Toronto General Hospital, co-scientific director of the Schwartz Reisman Liver Research Centre and a Canada Research Chair Tier 2 in liver immunobiology. She is a Professor in the University of Toronto's department of Laboratory Medicine and Pathobiology and the department of Immunology.

Raj Shah is an advanced endoscopist at The Ohio State University. As a clinical expert and researcher, he is the co-leader of the bariatric and metabolic endoscopy program. He completed his advanced and bariatric endoscopy training at Brigham and Women's Hospital, Harvard Medical School. He is also a GRADE methodologist and an expert in evidence based medicine. He has lead and co-authored several guidelines in the field of gastroenterology and obesity.

Fasiha Kanwal, MD, MSHS is the Nancy Chang Endowed Professor of Medicine, Director of the Institute for Clinical and Translational Research, and associate dean for clinical and translational research at Baylor College of Medicine. She also serves as the contact principal investigator for Baylor College of Medicine and University of Houston new CTSA grant. Dr. Kanwal has been recognized with numerous awards for her research on risk and risk factors for hepatocellular cancer and quality of care delivered to patients with liver disease.

Dr. Satyavada is a board-certified gastroenterologist with additional training in transplant hepatology and advanced endoscopy. Her specific interests include the application of endoscopic ultrasound and ERCP to pancreaticobiliary disease and hepatology. By combining these fields, she is able to offer endoscopic procedures to patients with advanced liver and pancreatic disease and her clinical aim is to continue to build a niche in endo-hepatology.